Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LONP1 | P36776 | 14/20 | 0.49 |
| ▸ | PSMB5 | P28074 | 7/20 | 0.47 |
| ▸ | PSMB11 | A5LHX3 | 6/20 | 0.47 |
| ▸ | PSMA7 | O14818 | 6/20 | 0.47 |
| ▸ | PSMB1 | P20618 | 6/20 | 0.47 |
| ▸ | PSMA1 | P25786 | 6/20 | 0.47 |
| ▸ | PSMA2 | P25787 | 6/20 | 0.47 |
| ▸ | PSMA3 | P25788 | 6/20 | 0.47 |
| ▸ | PSMA4 | P25789 | 6/20 | 0.47 |
| ▸ | PSMB8 | P28062 | 6/20 | 0.47 |
| ▸ | PSMB9 | P28065 | 6/20 | 0.47 |
| ▸ | PSMA5 | P28066 | 6/20 | 0.47 |
| ▸ | PSMB4 | P28070 | 6/20 | 0.47 |
| ▸ | PSMB6 | P28072 | 6/20 | 0.47 |
| ▸ | PSMB10 | P40306 | 6/20 | 0.47 |
| ▸ | PSMB3 | P49720 | 6/20 | 0.47 |
| ▸ | PSMB2 | P49721 | 6/20 | 0.47 |
| ▸ | PSMA6 | P60900 | 6/20 | 0.47 |
| ▸ | PSMA8 | Q8TAA3 | 6/20 | 0.47 |
| ▸ | PSMB7 | Q99436 | 6/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25286303 | 1.00 | LONP1 (0.49) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL25286304 | 1.00 | LONP1 (0.49) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL9158915 | 0.96 | LONP1 (0.48) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL9158908 | 0.96 | LONP1 (0.48) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL9830710 | 0.83 | LONP1 (0.63) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL9830718 | 0.83 | LONP1 (0.63) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL22610052 | 0.81 | LONP1 (0.51) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL22610053 | 0.81 | LONP1 (0.51) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL2151203 | 0.81 | LONP1 (0.46) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL2151194 | 0.81 | LONP1 (0.46) | LONP1PSMB5PSMB11PSMA7PSMB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220315554-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2022-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220315554-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | FIBP, FN1, TPX2 | LONP1 259/4885PSMB5 1447/4885PSMB11 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.